Stock vs Stock Comparison

Medtronic plc vs AbbVie Inc.

MDT and ABBV are evenly matched across key metrics.

MDT$83.20
ABBV$254.49

🏆 Tale of the Tape

44
MDTABBV
13.2%Profitability (Net Margin)6.9%
22.4xValuation (P/E)124.8x
6.7%Efficiency (ROIC)8.3%
7/9Health (Piotroski F)7/9
2.8Safety (Altman Z)2.4
8.4%Growth (Rev YoY)8.6%
-0.36Risk (Sharpe 1Y)1.11
0.86xBalance Sheet (D/E)-42.50x
4.15%FCF Yield3.54%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.289
252-Day Correlation
0.345
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricMDTABBV
Market Cap$106.5B$449.6B
P/E Ratio22.4x124.8x
Forward P/E13.0x15.6x
P/B2.15x-67.56x
Dividend Yield3.45%2.72%
Beta0.580.28

Quantitative Metrics

MetricMDTABBV
DCF Fair Value$89.22$123.27
DCF Upside+7.2%-51.6%
Piotroski F7/97/9
Altman Z2.782.37
Beneish M-2.58-2.87
FCF Yield4.15%3.54%
Net Debt/EBITDA2.5x3.0x
ROIC6.7%8.3%
WACC7.6%7.5%
ROIC – WACC-0.9pp0.7pp
Gross Margin65.0%70.2%
Net Margin13.2%6.9%
Rev Growth YoY8.4%8.6%
Sharpe (1Y)-0.361.11
Max Drawdown 3Y
FCF Payout Ratio67%65%

MDT Price

Loading chart...

ABBV Price

Loading chart...

ETF Exposure

MDT found in:

IHI4.40%
XLV1.83%
XHE1.60%
HDV1.55%
VHT1.48%
SDY1.36%
VFVA0.54%
MGV0.47%
VFMV0.46%
VIG0.44%
VYM0.42%
VTV0.38%
SPYV0.36%
VONV0.28%
ESGV0.22%
SPLG0.20%
SPY0.17%
VOO0.16%
SPTM0.15%
VONE0.14%
VTI0.14%
QUS0.14%
ONEO0.12%
VT0.08%

ABBV found in:

XLV7.69%
IYH7.48%
VHT6.56%
HDV5.44%
SCHD3.53%
DGRO3.05%
MGV2.10%
VIG1.94%
DGRW1.93%
VYM1.85%
JEPI1.73%
VTV1.66%
SDY1.61%
NOBL1.49%
IWF1.39%
SCHV1.38%
VONV1.15%
XBI1.11%
SPYV0.82%
ESGV0.78%
IVV0.72%
SPY0.69%
VOO0.69%
SPLG0.68%
SCHX0.66%
SPTM0.64%
VONE0.64%
ITOT0.63%
SCHB0.62%
VTI0.61%
SPYG0.59%
URTH0.48%
VFVA0.41%
VT0.38%
QUS0.38%
ACWI0.38%
VFMV0.25%
RSP0.18%
VONG0.11%
ONEO0.03%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

MDT vs ABBV: Head-to-Head Analysis

Medtronic plc (MDT) and AbbVie Inc. (ABBV) represent two companies in the Healthcare sector. Our quantitative Tale of the Tape shows these companies are evenly matched across profitability, valuation, and risk metrics.

In terms of capital efficiency, MDT generates a return on invested capital (ROIC) of 6.7% compared to ABBV's 8.3%. This suggests ABBV is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between MDT and ABBV is 0.289, indicating low correlation, making them an effective diversification pair in a portfolio context.

MDT appears in 24 ETFs tracked by SecuritiesDB, while ABBV appears in 40 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, MDT or ABBV?

Our quantitative analysis compares MDT and ABBV across nine fundamental dimensions. MDT and ABBV are evenly matched across key metrics. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are MDT and ABBV correlated?

The 252-day correlation between MDT and ABBV is 0.289. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.